Analysts Expect Natera Inc (NTRA) to Post -$0.43 Earnings Per Share
Equities research analysts forecast that Natera Inc (NASDAQ:NTRA) will report earnings of ($0.43) per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Natera’s earnings. The highest EPS estimate is ($0.37) and the lowest is ($0.47). Natera posted earnings of ($0.72) per share during the same quarter last year, which would suggest a positive year over year growth rate of 40.3%. The firm is expected to announce its next quarterly earnings report on Tuesday, March 6th.
According to Zacks, analysts expect that Natera will report full-year earnings of ($2.15) per share for the current year, with EPS estimates ranging from ($2.17) to ($2.11). For the next financial year, analysts anticipate that the company will post earnings of ($1.31) per share, with EPS estimates ranging from ($1.59) to ($0.86). Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that follow Natera.
Natera (NASDAQ:NTRA) last issued its earnings results on Wednesday, November 8th. The medical research company reported ($0.51) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.47) by ($0.04). Natera had a negative return on equity of 197.09% and a negative net margin of 62.34%. The firm had revenue of $56.66 million during the quarter, compared to the consensus estimate of $55.31 million. During the same period last year, the firm posted ($0.50) earnings per share. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year.
Shares of Natera (NTRA) opened at $10.18 on Monday. Natera has a twelve month low of $7.35 and a twelve month high of $14.76. The company has a debt-to-equity ratio of 2.43, a current ratio of 1.85 and a quick ratio of 1.75. The stock has a market capitalization of $547.37, a PE ratio of -4.16 and a beta of 2.07.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Virtu KCG Holdings LLC purchased a new position in Natera in the second quarter worth about $126,000. Los Angeles Capital Management & Equity Research Inc. purchased a new position in Natera in the second quarter worth about $151,000. Voya Investment Management LLC grew its position in Natera by 17.8% in the second quarter. Voya Investment Management LLC now owns 14,663 shares of the medical research company’s stock worth $159,000 after acquiring an additional 2,212 shares in the last quarter. Russell Investments Group Ltd. purchased a new position in Natera in the third quarter worth about $171,000. Finally, Wells Fargo & Company MN grew its position in Natera by 2.8% in the second quarter. Wells Fargo & Company MN now owns 18,031 shares of the medical research company’s stock worth $195,000 after acquiring an additional 491 shares in the last quarter. Institutional investors own 66.06% of the company’s stock.
Natera Company Profile
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Natera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera and related companies with MarketBeat.com's FREE daily email newsletter.